Featuring slide presentations and related
discussion from Dr Lipika Goyal, Dr James J Harding, Dr Milind
Javle and Dr Robin K (Katie) Kelley, including the following
topics:
Current Role of Immunotherapeutic Strategies
for Advanced Biliary Tract Cancers (BTCs) — Dr Kelley (0:00)
Case: A man in his late 60s with advanced
distal cholangiocarcinoma treated with the TOPAZ-1 regimen
(13:27)
Case: A woman in her early 70s with recurrent
gallbladder cancer with biliary obstruction (15:56)
Targeting FGFR and IDH Alterations for
Advanced BTCs — Dr Goyal (35:00)
Case: A woman in her late 30s with FGFR2
fusion-positive intrahepatic cholangiocarcinoma (ICC) (54:25)
Case: A man in his late 60s with
cholangiocarcinoma metastases to liver and bone (1:01:33)
Case: A woman in her 60s with ICC with an
IDH1 mutation (1:10:05)
Emerging Role of HER2-Targeted Therapy for
Advanced BTCs — Dr Harding (1:21:15)
Case: A man in his early 40s with
cholangiocarcinoma metastatic to the appendix (1:57:25)
New Directions in the Management of BTCs — Dr
Javle (2:01:09)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.